Role of bradykinin in preconditioning and protection of the ischaemic myocardium

Br J Pharmacol. 2002 Feb;135(4):843-54. doi: 10.1038/sj.bjp.0704548.

Authors

G F Baxter¹, Z Ebrahim

Affiliation

¹ The Hatter Institute, University College London, London. gfbaxter@rvc.ac.uk

No abstract available

Publication types

Review

MeSH terms

Aminopeptidases / antagonists & inhibitors
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Animals
Apoptosis / drug effects
Autocrine Communication
Bradykinin / biosynthesis
Bradykinin / metabolism*
Bradykinin / pharmacology
Humans
Ischemic Preconditioning, Myocardial*
Myocardial Ischemia / metabolism*
Myocardial Ischemia / prevention & control
Myocardial Reperfusion Injury / metabolism
Myocardial Reperfusion Injury / prevention & control
Neprilysin / antagonists & inhibitors
Paracrine Communication

Substances

Angiotensin-Converting Enzyme Inhibitors
Aminopeptidases
X-Pro aminopeptidase
Neprilysin
Bradykinin